Is Aspirin Still the Cornerstone of Antiplatelet Therapy in Patients With Coronary Artery Disease? An Historical and Practical Narrative Review-Reference-Cited by-同舟云学术

Is Aspirin Still the Cornerstone of Antiplatelet Therapy in Patients With Coronary Artery Disease? An Historical and Practical Narrative Review

Published:2017-08-22 Issue:4 Volume:2 Page:94-101
ISSN:2476-3918
Container-title:Hospital Practices and Research
language:en
Short-container-title:Hosp Pract Res

Author:

Gravinese Carol,Bianco Matteo,Cerrato Enrico,Destefanis Paola,Luciano Alessia,Bernardi Alessandro,Bellucca Simone,Varbella Ferdinando,Gaita Fiorenzo,Pozzi Roberto

Publisher

Maad Rayan Publishing Company

Subject

Geology,Ocean Engineering,Water Science and Technology

Link

http://jhpr.ir/article_49556_72a3e11c4858402b6b11c40de8732806.pdf

Cited by 6 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Current Strategies to Guide the Antiplatelet Therapy in Acute Coronary Syndromes;International Journal of Molecular Sciences;2024-04-03

2. Ticagrelor or Clopidogrel After an Acute Coronary Syndrome in the Elderly: A Propensity Score Matching Analysis from 16,653 Patients Treated with PCI Included in Two Large Multinational Registries;Cardiovascular Drugs and Therapy;2021-07-05

3. P2Y12 inhibitors monotherapy after short course of dual antiplatelet therapy in patients undergoing percutaneous coronary intervention: a meta-analysis of randomized clinical trials including 29 089 patients;European Heart Journal - Cardiovascular Pharmacotherapy;2020-06-16

4. Comparative external validation of the PRECISE-DAPT and PARIS risk scores in 4424 acute coronary syndrome patients treated with prasugrel or ticagrelor;International Journal of Cardiology;2020-02

5. Omitting aspirin in PCI patients: Myth or reality?;Cardiovascular Drugs and Therapy;2019-12